Volume 9, Number 7—July 2003
Dispatch
Leishmaniasis in Germany
Gundel Harms*
, Gabriele Schönian*, and Hermann Feldmeier†
, Gabriele Schönian*, and Hermann Feldmeier†
Table 2
Characteristics of patients with visceral leishmaniasis, Germanya
| No. | Exposure | Status | Sex | Age | Risk factor | Leishmania species | Treatment | Outcome |
|---|---|---|---|---|---|---|---|---|
| 1 |
Italy |
Tourist |
M |
2 y |
Child |
n.d. |
Liposomal amphotericin B |
Cured |
| 2 |
Italy |
Tourist |
F |
5 y |
Child |
n.d. |
Liposomal amphotericin B |
Cured |
| 3 |
Italy |
Tourist |
M |
11 y |
Child |
n.d. |
Liposomal amphotericin B |
Cured |
| 4 |
Spain |
Tourist |
F |
8 mo |
Child |
n.d. |
Liposomal amphotericin B |
Cured |
| 5 |
Spain |
Tourist |
M |
9 mo |
Child |
L. donovani complex |
Liposomal amphotericin B |
Cured |
| 6 |
Iran |
Immigrant |
M |
7 y |
Child |
L. donovani complex |
Liposomal amphotericin B |
Cured |
| 7 |
Spain |
Tourist |
M |
43 y |
HIV |
L. donovani complex |
Liposomal amphotericin B;
Maintenance therapy:
HAART plus liposomal amphotericin B once monthly |
No relapse for 6 months |
| 8 |
Spain (Ibiza) |
Tourist |
M |
48 y |
HIV |
L. donovani complex |
Liposomal amphotericin B;
Maintenance therapy:
HAART plus liposomal amphotericin B once monthly |
No relapse for 8 months |
| 9 |
Portugal |
Visitor |
M |
29 y |
HIV |
n.d. |
Liposomal amphotericin B;
Maintenance therapy:
HAART plus liposomal amphotericin B once monthly |
unknown |
| 10 |
France |
Tourist |
M |
31y |
HIV |
L. donovani complex |
Liposomal amphotericin B;
Maintenance therapy:
HAART plus liposomal amphotericin B once monthly |
Relapse after 4 months; retreatment with Liposomal Amphotericin B; No relapse for 3 months |
| 11 |
Angola |
Immigrant |
M |
40 y |
HIV |
L. donovani complex |
Systemic pentavalent antimonials
Maintenance therapy:
HAART plus pentavalent antimonials once monthly |
unknown |
| 12 |
Togo |
Immigrant |
M |
37 y |
HIV |
L. donovani complex |
Liposomal amphotericin B |
Cured |
| 13 |
Italy (Sicily) |
Visitor |
M |
31 y |
Thymoma |
n.d. |
Liposomal amphotericin B |
Cured |
| 14 |
Italy (Ischia) |
Tourist |
M |
67 y |
Methotrexate/steroids |
L. donovani complex |
Liposomal amphotericin B |
Cured |
| 15 |
Italy (Sicily) |
Tourist |
M |
68 y |
Methotrexate |
n.d. |
Liposomal amphotericin B |
Cured |
| 16 |
Italy (Ischia) |
Tourist |
M |
70 y |
Splenectomy |
n.d. |
Liposomal amphotericin B |
Cured |
| 17 |
Spain |
Tourist |
M |
51 y |
Splenectomy |
L. donovani complex |
Liposomal amphotericin B |
Cured |
| 18 |
Greece (Korfu) |
Tourist |
M |
66 y |
Diabetes mellitus Hypertonus |
n.d. |
Liposomal amphotericin B |
Cured |
| 19 |
Spain |
Tourist |
M |
52 y |
Hypertonus
Hypercholesterolemia |
n.d. |
Liposomal amphotericin B |
Cured |
| 20 |
Greece (Korfu) |
Tourist |
M |
45 y |
Diabetes mellitus
Emphysema |
L. donovani complex |
Systemic pentavalent antimonoials |
Cured |
| 21 |
Tunisia |
Tourist |
M |
53 y |
Hypertonus |
L. donovani complex |
Liposomal amphotericin B |
Cured |
| 22 |
Malta |
Tourist |
F |
55 y |
- |
n.d. |
Liposomal amphotericin B |
Cured |
| 23 | China | Tourist | M | 67 y | - | n.d. | Liposomal amphotericin B | Cured |
an.d., not done; IFN, interferon.
Page created: December 22, 2010
Page updated: December 22, 2010
Page reviewed: December 22, 2010
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.